Aperam (XMAD:APAM) Other Long-Term Liabilities: €142 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:APAM Aperam SA XMAD:APAM
83 GF Score
Price €45.52
GF Value €26.60
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Aperam Other Long-Term Liabilities?

Aperam XMAD:APAM 83 Other Long-Term Liabilities is €142 Mil as of Jun. 2026. GuruFocus rates XMAD:APAM with a GF Score™ of 83/100 and a GF Value™ of €26.60 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Aperam's other long-term liabilities for the quarter that ended in Jun. 2026 was €142 Mil.

Aperam's quarterly other long-term liabilities declined from Dec. 2025 (€145 Mil) to Mar. 2026 (€133 Mil) but then increased from Mar. 2026 (€133 Mil) to Jun. 2026 (€142 Mil).

Aperam's annual other long-term liabilities declined from Dec. 2023 (€186 Mil) to Dec. 2024 (€146 Mil) and declined from Dec. 2024 (€146 Mil) to Dec. 2025 (€145 Mil).

Aperam Other Long-Term Liabilities Related Terms

Aperam Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Aperam's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aperam Other Long-Term Liabilities Chart

Aperam Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 200.00 203.00 186.00 146.00 145.00

Aperam Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 157.00 155.00 145.00 133.00 142.00
XMAD:APAM
83GF Score
Aperam SA XMAD:APAM
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aperam Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €142 Mil mean?
Aperam (XMAD:APAM) has a Other Long-Term Liabilities of €142 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Aperam and its competitors.
Is Aperam's Other Long-Term Liabilities too high?
Aperam's current Other Long-Term Liabilities is €142 Mil. Overall, Aperam has a GF Score™ of 83/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aperam's Other Long-Term Liabilities compare to NUE and STLD?
Aperam's Other Long-Term Liabilities of €142 Mil can be compared against companies in the Steel industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Steel company?
A good Other Long-Term Liabilities depends on the Steel industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Aperam and its competitors. Aperam's current Other Long-Term Liabilities is €142 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aperam stock overvalued right now?
Based on GuruFocus' analysis, Aperam (XMAD:APAM) is currently considered Significantly Overvalued. The stock's GF Value™ is €26.60, compared to a current price of €45.52 — trading 71.1% above its estimated fair value. The current Other Long-Term Liabilities is €142 Mil. Aperam's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Aperam (XMAD:APAM), the current Other Long-Term Liabilities is €142 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aperam (XMAD:APAM) Overvalued in 2026?

Based on GuruFocus' analysis, Aperam stock appears to be overvalued. The current stock price of €45.52 is trading 71.1% above its estimated GF Value™ of €26.60. GuruFocus considers Aperam to be Significantly Overvalued.

Key valuation signals for XMAD:APAM:

  • Other Long-Term Liabilities: €142 Mil
  • GF Value™: €26.60 vs. price of €45.52 (71.1% above fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the XMAD:APAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aperam Business Description

Address 24-26 Boulevard d’Avranches, Luxembourg, LUX, 1160
Aperam SA is a Luxembourg-based stainless and specialty steel producer. The company operates through four segments. Its Stainless and Electrical Steel segment, which generates the majority of revenue, produces a wide range of stainless and electrical steel products for diverse industries. The Services and Solutions segment markets the company's products and provides customized steel transformation services; the Alloys and Specialties segment produces nickel alloys and certain specific stainless steels; and the Recycling & Renewables segment collects, trades, processes, and recycles stainless steel scrap and high-performance alloys. Geographically, the company generates maximum revenue from Europe, and the rest from the Americas, Asia, and Africa.
83GF Score

Get the complete analysis for XMAD:APAM

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€45.52
Price
€26.60
GF Value